Return On Assets of Sage Therapeutics, Inc. from 31 Mar 2015 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Sage Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2015 to 30 Jun 2025.
  • Sage Therapeutics, Inc. Return On Assets for the quarter ending 30 Jun 2025 was -58%, a 8% decline year-over-year.
  • Sage Therapeutics, Inc. annual Return On Assets for 2024 was -61%, a 16% decline from 2023.
  • Sage Therapeutics, Inc. annual Return On Assets for 2023 was -52%, a 51% decline from 2022.
  • Sage Therapeutics, Inc. annual Return On Assets for 2022 was -35%, a 49% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Sage Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -58% -4% -8% 01 Apr 2025 30 Jun 2025
Q1 2025 -61% -6% -11% 01 Jan 2025 31 Mar 2025
Q4 2024 -61% -8% -16% 01 Oct 2024 31 Dec 2024
Q3 2024 -45% +11% +20% 01 Jul 2024 30 Sep 2024
Q2 2024 -54% -8% -18% 01 Apr 2024 30 Jun 2024
Q1 2024 -55% -15% -39% 01 Jan 2024 31 Mar 2024
Q4 2023 -52% -18% -51% 01 Oct 2023 31 Dec 2023
Q3 2023 -57% -26% -85% 01 Jul 2023 30 Sep 2023
Q2 2023 -46% -17% -61% 01 Apr 2023 30 Jun 2023
Q1 2023 -39% -13% -52% 01 Jan 2023 31 Mar 2023
Q4 2022 -35% -11% -49% 01 Oct 2022 31 Dec 2022
Q3 2022 -31% -62% -198% 01 Jul 2022 30 Sep 2022
Q2 2022 -29% -67% -175% 01 Apr 2022 30 Jun 2022
Q1 2022 -26% -70% -159% 01 Jan 2022 31 Mar 2022
Q4 2021 -23% -75% -145% 01 Oct 2021 31 Dec 2021
Q3 2021 31% +91% 01 Jul 2021 30 Sep 2021
Q2 2021 38% +98% 01 Apr 2021 30 Jun 2021
Q1 2021 44% +100% 01 Jan 2021 31 Mar 2021
Q4 2020 52% +106% 01 Oct 2020 31 Dec 2020
Q3 2020 -60% -5% -9.2% 01 Jul 2020 30 Sep 2020
Q2 2020 -60% -9% -16% 01 Apr 2020 30 Jun 2020
Q1 2020 -57% -16% -40% 01 Jan 2020 31 Mar 2020
Q4 2019 -54% -19% -54% 01 Oct 2019 31 Dec 2019
Q3 2019 -55% -25% -84% 01 Jul 2019 30 Sep 2019
Q2 2019 -52% -21% -66% 01 Apr 2019 30 Jun 2019
Q1 2019 -41% +12% +23% 01 Jan 2019 31 Mar 2019
Q4 2018 -35% +41% +53% 01 Oct 2018 31 Dec 2018
Q3 2018 -30% +49% +62% 01 Jul 2018 30 Sep 2018
Q2 2018 -31% +28% +48% 01 Apr 2018 30 Jun 2018
Q1 2018 -53% -2% -4.9% 01 Jan 2018 31 Mar 2018
Q4 2017 -76% -31% -69% 01 Oct 2017 31 Dec 2017
Q3 2017 -79% -35% -81% 01 Jul 2017 30 Sep 2017
Q2 2017 -59% -11% -23% 01 Apr 2017 30 Jun 2017
Q1 2017 -50% -4% -8.4% 01 Jan 2017 31 Mar 2017
Q4 2016 -45% +6% +12% 01 Oct 2016 31 Dec 2016
Q3 2016 -44% +2% +4.8% 01 Jul 2016 30 Sep 2016
Q2 2016 -48% -7% -16% 01 Apr 2016 30 Jun 2016
Q1 2016 -47% -5% -13% 01 Jan 2016 31 Mar 2016
Q4 2015 -51% 01 Oct 2015 31 Dec 2015
Q3 2015 -46% 01 Jul 2015 30 Sep 2015
Q2 2015 -42% 01 Apr 2015 30 Jun 2015
Q1 2015 -41% 01 Jan 2015 31 Mar 2015

Sage Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -61% -8% -16% 01 Jan 2024 31 Dec 2024
2023 -52% -18% -51% 01 Jan 2023 31 Dec 2023
2022 -35% -11% -49% 01 Jan 2022 31 Dec 2022
2021 -23% -75% -145% 01 Jan 2021 31 Dec 2021
2020 52% +106% 01 Jan 2020 31 Dec 2020
2019 -54% -19% -54% 01 Jan 2019 31 Dec 2019
2018 -35% +41% +53% 01 Jan 2018 31 Dec 2018
2017 -76% -31% -69% 01 Jan 2017 31 Dec 2017
2016 -45% +6% +12% 01 Jan 2016 31 Dec 2016
2015 -51% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.